Zoetis ZTS
NYSE ZTS
$73.31 -0.25 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zoetis (ZTS) Cash from Operations (2012 - 2026)

Zoetis' (ZTS) quarterly Cash from Operations came in at $655.0 million in Q2 2026, up 8.26% year-over-year from $605.0 million in Q2 2025, and up 63.34% quarter-over-quarter from $401.0 million in Q1 2026.

Analysis

Zoetis (ZTS) Cash from Operations (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Cash from Operations for 15 consecutive years, with $655.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Operations rose 8.26% year-over-year to $655.0 million in Q2 2026; TTM through Jun 2026 was $2.8 billion, a 4.57% decrease from a year earlier, with the FY2025 full-year figure at $2.9 billion, down 1.66% from the prior year.
  • Cash from Operations was $655.0 million for Q2 2026 at Zoetis, up from $401.0 million in the prior quarter.
  • Over five years, Cash from Operations peaked at $951.0 million in Q3 2024 and troughed at $183.0 million in Q2 2023.
  • A 5-year average of $621.0 million and a median of $600.0 million in 2024 frame the typical range for Cash from Operations.
  • Across the five-year window, Cash from Operations slumped 45.54% in 2023 and soared 174.32% in 2024, its largest moves.
  • Over 5 years, Cash from Operations stood at $741.0 million in 2022, then advanced by 21.05% to $897.0 million in 2023, then advanced by 0.89% to $905.0 million in 2024, then decreased by 1.33% to $893.0 million in 2025, then decreased by 26.65% to $655.0 million in 2026.
  • The last three Cash from Operations figures came in at $655.0 million (Q2 2026), $401.0 million (Q1 2026), and $893.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn 347.16 Mn
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn 655.00 Mn
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn 277.00 Mn
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn 24.09 Mn
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -133,565.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 655.00 Mn
Mar 31, 2026 401.00 Mn
Dec 31, 2025 893.00 Mn
Sep 30, 2025 891.00 Mn
Jun 30, 2025 605.00 Mn
Mar 31, 2025 515.00 Mn
Dec 31, 2024 905.00 Mn
Sep 30, 2024 951.00 Mn
Jun 30, 2024 502.00 Mn
Mar 31, 2024 595.00 Mn
Dec 31, 2023 897.00 Mn
Sep 30, 2023 724.00 Mn
Jun 30, 2023 183.00 Mn
Mar 31, 2023 549.00 Mn
Dec 31, 2022 741.00 Mn
Sep 30, 2022 526.00 Mn
Jun 30, 2022 336.00 Mn
Mar 31, 2022 309.00 Mn
Dec 31, 2021 679.00 Mn
Sep 30, 2021 653.00 Mn